HCT-8 In Vitro Anti-Tumor Efficacy Assay

CAT#: ITS-1122-YF207
Target Cell Organism: Human
Target Cell Alternative Name: HRT-18
Target Cell Name: HCT-8
Assay Type: Oncology Efficacy Assays
Assay Overview
This assay is to provide HCT-8-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
HCT-8
Target Cell Organism
Human
Target Cell Background
HCT-8 [HRT-18] cells were isolated from the large intestine of a 67-year-old, male, adenocarcinoma patient. HCT-8 [HRT-18] are used for cancer and toxicology research.
Target Cell Alternative Name
HRT-18
Related Diseases
Colorectal Adenocarcinoma; Colon Cancer
Research Area
Oncology
Assay Name
In Vitro Anti-Tumor Efficacy Assay
Short Description
HCT-8-cell based In Vitro Anti-Tumor Efficacy Assay
Assay Description
Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.
Assay Type
Oncology Efficacy Assays
For Research Use Only | Not For Clinical Use
Online Inquiry